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Background: The beneficial role of exercise in maintaining health in patients with Cystic Fibrosis
(CF) is well described. Few data exist on the effect of exercise on respiratory muscle function in
patients with CF. Our objective was to compare respiratorymuscle function indices in CF patients
that regularly exercise with those CF patients that do not.
Methods: This cross-sectional study assessed nutrition, pulmonary function and respiratory mus-
cle function in 37 CF patients that undertook regular aerobic exercise and in a control group
matched for age and gender which consisted of 44 CF patients that did not undertake regular ex-
ercise. Respiratory muscle function in CF was assessed by maximal inspiratory pressure (Pimax),
maximal expiratory pressure (Pemax) and pressure-time index of the respiratory muscles (PTImus).
Results: Median Pimax and Pemax were significantly higher in the exercise group compared to the
control group (92 vs. 63 cmH20 and 94 vs. 64 cmH20 respectively). PTImus was significantly lower in
the exercise group compared to the control group (0.089 vs. 0.121). Upper arm muscle area
(UAMA) and mid-arm muscle circumference were significantly increased in the exercise group
compared to the control group (2608 vs. 2178 mm2 and 23 vs. 21 cm respectively). UAMA was sig-
nificantly related to Pimax in the exercising group.
Conclusions: These results suggest thatCF patients that undertake regular aerobic exercisemain-
tain higher indices of respiratory muscle strength and lower PTImus values, while increased UAMA
values in exercising patients highlight the importance ofmuscular competence in respiratorymus-
cle function in this population.
ª 2013 Elsevier Ltd. All rights reserved.e’s Hospital, Cambridge University Hospitals NHS Trust, Hills Road, Cambridge, CB2 0SW, UK. Tel.: þ44
r (T. Dassios).
3 Elsevier Ltd. All rights reserved.
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Exercise and respiratory muscles in cystic fibrosis 685IntroductionIn cystic fibrosis (CF) patients, cumulative pulmonary in-
fections lead to a gradual decline in lung function while
nutritional impairment is common.1 Respiratory muscle
function is affected by chronic obstructive pulmonary dis-
ease and chronic nutritional deficiency.2
Physical activity plays an important role in maintaining
health in patients with CF.3 Regular aerobic exercise slows
the rate of lung function decline,4 while exercise combined
with physical therapy has been associated with a statisti-
cally significant increase in FEV1 over physical therapy
alone.5 Furthermore, exercise has been reported to
increase peak aerobic capacity, level of activity and quality
of life.6 A single exercise bout resulted in inhibition of
epithelial sodium channels in patients with CF partially
normalizing transepithelial potential difference,7 while
progressive aerobic exercise resulted in increased recruit-
ment in lung ventilation.8 Following a supervised three-
month running conditioning program, CF patients exhibi-
ted increased ventilatory muscle endurance.9 CF patients
subjected to high intensity exercise training did not
develop overt low frequency fatigue of the respiratory
muscles.10
Respiratory muscle strength can be assessed by meas-
urement of maximal inspiratory pressure (Pimax) and
maximal expiratory pressure (Pemax).
11 Respiratory muscle
function can be evaluated by measurement of the non-
invasive pressure-time index of the respiratory muscles
(PTImus).
12 PTImus is a composite index of respiratory
muscle efficiency that incorporates the mean inspiratory
pressure developed by the inspiratory muscles during
inspiration (Pimean) in relation to the maximal inspiratory
pressure (Pimax), and the duration of inspiration (Ti) in
relation to the total time of respiration (Ttot).12 Higher
efficiency of the respiratory muscles is demonstrated by
lower values of PTImus, while high PTImus values are rela-
ted to increased risk of respiratory muscle fatigue.12 To
our knowledge, no data exist in the literature, relating
exercise to respiratory muscle function assessed by
measurement of PTImus.
Our hypothesis was that patients with CF who under-
take regular aerobic exercise would exhibit improved
respiratory muscle function compared to CF patients that
do not undertake regular physical activity. The objective
of this study was, therefore, to compare respiratory
muscle function by measurement of Pimax, Pemax and
PTImus between exercising and non-exercising CF patients
with no gross hyperinflation, and investigate whether the
weekly amount of time spent on aerobic exercise sig-
nificantly relates to indices of respiratory muscle
function.Methods and materials
Study design
This was an observational cross-sectional study which con-
stituted part of a trial investigating respiratory muscle
function in patients with CF.Subjects
CF patients attending their follow up appointments in the
Department of Cystic Fibrosis of Aghia-Sophia Children’s
Hospital in Athens, Greece were eligible for the study. The
diagnosis of CF was confirmed by abnormal sweat-test re-
sults and confirmed with expanded mutation analysis.13
Patients in acute exacerbation during the past month, pa-
tients on steroid treatment, patients with evidence of
marked hyperinflation on chest radiography or computed
tomography and patients with coexisting respiratory dis-
eases were excluded from the study. Standard chest phys-
ical therapy was undertaken by all CF patients.Measurements
Equipment
Airway flow was recorded with a pneumotachograph (Mer-
cury F100L, GM Instruments, Kilwinning, Scotland) con-
nected to a differential pressure transducer (DP45,
range  3.5 cm H2O, Validyne Corp, Northridge, CA, USA).
Airway pressure (Paw) was measured from a side port on
the pneumotachograph, which was connected to a differ-
ential pressure transducer (DP45, range  225 cm H2O,
Validyne Corp, Northridge, CA, USA). Amplification of the
signals from the differential pressure transducers was per-
formed by a carrier amplifier (Validyne CD 280, Validyne
Corp, Northridge, CA, USA). Amplified signals were recor-
ded and displayed in real time on a computer (Dell Optiplex
GX620, Dell Inc., Texas, U.S.A) running Labview software
(National Instruments, Austin, Texas, U.S.A) with analog-to-
digital sampling at 100 Hz (16-bit NI PCI-6036E, National
Instruments, Austin, Texas, U.S.A).
Measurement of respiratory pressures, breathing cycle
components and lung function parameters
Airway pressure generated 100 ms after an occlusion (P0.1),
Pimax, Pemax, respiration rate (RR), tidal volume (TV),
minute ventilation (MV), inspiratory time (Ti), total time of
respiration (Ttot) and inspiratory time ratio (Ti/Ttot) were
measured. P0.1 was calculated as the airway pressure gen-
erated 100 msec after an occlusion while the child/adult
was quietly breathing. Five or more airway occlusions were
performed and the average P0.1 value was calculated. Pimax
was measured from Residual Volume against an occluded
airway upon a maximal inspiratory effort.14 Pemax was
measured from Total Lung Capacity against an occluded
airway upon a maximal expiratory effort.14 Pimax and Pemax
were measured on the basis of five maximal reproducible
respiratory efforts and the maximum achieved value was
recorded. A unidirectional valve (dead-space 8 ml)
attached to the rubber mouthpiece was utilized to perform
the occlusions. A small needle leak was incorporated in the
respiratory circuit in order to avoid artificial glottic clo-
sure.11 Care was taken to eliminate any leak around the
mouthpiece. Only Pimax and Pemax maneuvers with plateau
pressure of at least 1 s were accepted for subsequent
analysis.11 Forced expiratory volume in 1 s (FEV1), Maximal
Expiratory Flow between 25 and 75% of VC (MEF25-75) and
Forced vital capacity (FVC) were measured with a pneu-
motachograph using a Jager-Masterscreen Pulmonary
686 T. Dassios et al.Function analyzer (Jager AG, Wurzburg, Germany). The
pulmonary function tests were performed in accordance to
European Respiratory Society guidelines15 and expressed as
percentage of normal values (%predicted).16,17
Calculation of PTImus
The pressure-time index of the inspiratory muscles (PTImus),
was calculated as: PTImusZ (Pimean/Pimax) (Ti/Ttot),where
Pimean was the average airway pressure during inspiration,
obtained from the formula PimeanZ 5  P0.1  Ti, Pimax was
the maximum inspiratory airway pressure, Ti was the inspi-
ration time and Ttot was the total time for each breath,
calculated from the airway flow signal.12,18,19
Nutritional parameters
Body Mass Index (BMI) was calculated as the individual’s
body weight in kilograms divided by the square of his height
in meters.17 For patients aged 6e19 years of age the BMI z-
score method was used while patients older than 20 years,
were evaluated with the BMI method.20 Mid-arm muscle
circumference (MAMC) was measured to the nearest cen-
timeter, midway between the tip of the acromion and the
olecranon process with the right hand hanging relaxed.21
Triceps Skinfold Thickness (TST) was measured to the
nearest millimeter, halfway over the triceps muscle by
a Harpenden Skinfold Caliper (Baty International, UK) and
with the skinfold parallel to the longitudinal axis of the
humerus.21 Upper Arm Muscle Area (UAMA) was derived and
calculated from these indices.22
Exercise
The nature and degree of physical activity was assessed by
questionnaire. Patients that formed the exercise group
engaged in moderate to vigorous aerobic physical activity
at least three times a week over the past three months for
forty-five minutes each time.9,23,24 Activities that were
accepted as moderate to vigorous physical activity were
cycling, running, swimming, football, basketball, volley-
ball, athletics, tennis, martial arts, gymnastics and row-
ing.23,25 Total training hours per week were calculated on
the basis of the average training hours per week of the
three previous consecutive weeks prior to the measure-
ments. CF patients that did not participate in planned
physical activity formed the control group.
Statistics
Data were assessed for normality using the Kolmogor-
oveSmirnoff and ShapiroeWilk tests. Differences between
groups were checked for significance using the Man-
neWhitney rank sum test. Linear regression analysis was
used to examine the relation of PTImus, Pimax and Pemax to
total training hours per week and the relation of PTImus,
Pimax and Pemax to UAMA, BMI and BMI z-score. Variables
without normal distribution were logarithmically
transformed.
Statistical analysis was performed using SPSS 17.0 (SPSS
Inc, Chicago IL, USA).Ethics approval
The study protocol was approved by the Hospital Ethics
Committee. Parents, legal guardians or patients provided
informed written consent prior to the study.Results
Between November 2009 and April 2010, 113 potentially
eligible patients were evaluated. 32 patients were exclu-
ded according to the criteria described above. 81 patients
were included in the study. The exercise group comprised
of 37 CF patients while the control group consisted of 44 CF
patients matched as possible for age and sex. Ages ranged
from 7 to 34 years.
Anthropometric, nutrition, pulmonary function and res-
piratory muscle function data in the exercise and the con-
trol groups are presented in Table 1. The median value of
exercise hours per week was 6 and the interquartile range
4e8. Exercise characteristics of the study population are
presented in Table 2. Weight, height, BMI, BMI z-score and
TST were not significantly different in the exercise com-
pared to the control groups. MAMC and UAMA were sig-
nificantly increased in the exercise group compared to the
control group (Table 1).
FEV1, MEF25e75 and FVC did not exhibit significant dif-
ference between the two groups (Table 1). Breathing cycle
components such as TV, TV/kg, TV/Ti, MV, RR, Ti, Ttot and
Ti/Ttot were not significantly different between the two
groups (Table 1).
Pimax and Pemax (Fig. 1) were significantly increased
while PTImus (Fig. 2) and Pimean/Pimax, were marginally
significantly decreased in the exercise group of patients
compared to the control group (Table 1).
In the exercise group, there was a significant positive
relation between UAMA and Pimax (r Z 0.356, p Z 0.031)
but not between UAMA and Pemax or PTImus. The number of
total exercise hours per week was not found to be sig-
nificantly related to any of Pimax, Pemax, PTImus, BMI z-score
or UAMA.Discussion
This study demonstrated that PTImus was significantly
decreased and Pimax and Pemax were significantly increased
in exercising CF patients compared to non-regularly exer-
cising CF patients. In the exercise group the amount of
hours per week spent in exercise was not significantly
related to the respiratory muscle indices examined.
The beneficial role of aerobic exercise in maintaining
health in CF has been extensively reported in previous
studies. A recent Cochrane review concluded that physical
training has a positive effect on exercise capacity, strength
and lung function.26 Exercise improves transepithelial po-
tential difference in the CF airway,7improves mucus
clearance,3 increases recruitment in lung ventilation8 and
enhances airway clearance.27 Aerobic capacity has been
related to improved survival, quality of life and profes-
sional achievement in patients with CF.28 Children with CF
who regularly exercise, enjoy improved quality of life while
Table 1 Anthropometric, nutrition, pulmonary function and respiratory muscle function data in the exercise and the control
groups.
CF, N Z 81
Exercise
N Z 37
Control
N Z 44
P value
Gender (male) 26 (70.3) 24 (54.5) 0.145**
Age (years) 14 (12e17) 13 (9e17) 0.085*
Weight (kg) 52 (38e62) 43 (31e60) 0.113*
Height (cm) 159 (145e170) 156 (130e166) 0.132*
BMI 22.0 (19.6e25.2) N Z 5 21.0 (17.9e23.2) N Z 8 0.464*
BMI z-score 0.04 (0.61 to 0.66) N Z 32 0.44 (0.60 to 0.97) N Z 36 0.559*
TST (mm) 11 (8e14) 12 (8e15) 0.575*
MAMC (cm) 23 (20e26) 21 (18e25) 0.042*
UAMA (mm2) 2608 (2.119e4216) 2178 (1788e3241) 0.029*
FEV1 (% pred) 99.1 (75.8e118.1) 100.5 (77.0e100.6) 0.909*
MEF25-75 (% pred) 73.0 (49.4e100.2) 74.8 (42.0e103.9) 0.954*
FVC (% pred) 106.3 (92.3e117.1) 104.3 (83.3) 0.539*
RR 18 (15e22) 19 (15e23) 0.898*
Ti (sec) 1.48 (1.18e175) 1.51 (1.24e1.90) 0.722*
Ttot (sec) 3.32 (2.65e3.98) 3.22 (2.67e4.09) 0.936*
Ti/Ttot 0.44 (0.42e0.45) 0.45 (0.43e0.47) 0.129*
TV (L) 0.54 (0.39e0.70) 0.49 (0.37e0.63) 0.282*
TV/kg (ml/kg) 10.6 (8.9e13.9) 10.4 (8.2e16.5) 0.872*
TV/Ti (L/sec) 0.34 (0.28e0.49) 0.35 (0.26e0.42) 0.201*
MV (L/min) 9.66 (6.96e12.54) 9.14 (6.83e11.14) 0.345*
Pemax (cmH2O) 94 (66e120) 64 (46e83) <0.001*
Pimax (cmH2O) 92 (79e108) 63 (51e86) <0.001*
P0.1 (cmH2O) 2.47 (1.96e3.79) 2.38 (1.58e3.22) 0.341*
Pimean (cmH2O) 18.3 (13.3e26.5) 17.9 (12.7e25.2) 0.409*
Pimean/Pimax 0.197 (0.139e0.298) 0.271 (0.194e0.362) 0.045*
PTImus 0.089 (0.064e0.126) 0.121 (0.090e0.159) 0.034*
*ManneWhitney rank sum test, values are presented as median (interquartile range).
**Pearson Chi-square test, values are presented as numbers (percentage).
BMI: Body mass index, BMI z-score: Body mass index z-score, TST: Triceps skinfold thickness, MAMC: Mid-arm muscle circumference,
UAMA: Upper arm muscle area, FEV1: forced expiratory volume in 1 s, MEF25e75: maximal expiratory flow between 25% and 75% of VC,
FVC: Forced vital capacity, RR: Respiratory rate, Ti: inspiratory time, Ttot: Total time of respiration, TV: Tidal volume, TV/kg: Tidal
volume per kilogram of body weight, TV/Ti: inspiratory flow, MV: Minute ventilation, Pemax: Maximal expiratory pressure, Pimax: Maximal
inspiratory pressure, P0.1: inspiratory pressure 100 msec after onset of inspiration, Pimean: Inspiratory pressure, PTImus: Pressure-time
index of the respiratory muscles,.
Exercise and respiratory muscles in cystic fibrosis 687there are also cost-benefit implications since they require
fewer resources for antibiotics.29 Exercise recommenda-
tions include various aerobic activities 3e5 times per week
for 20e45 min at intensity levels of 60e85% of maximum
heart rate depending on the severity of CF lung disease.25
Questionnaire-derived activity measurements are reliable
and valid tools in assessing physical activity in children with
CF while they also correlate to accelerometer measure-
ments which are thought to describe more reliably an in-
dividual’s aerobic condition.30,31
PTImus was initially assessed as an index to describe
inspiratory muscle function by Gaultier et al.,18 validated
by Ramonatxo et al.12 while Hayot et al.19 and Hahn et al.32
applied it in CF patients. PTImus is a non-invasive, global
respiratory muscle index, which does not overlook the
possible effects exerted in respiration by accessory respi-
ratory muscles. Our study reports similar PTImus values
compared to previous studies of PTImus in CF patients.
19,32
Maximal respiratory pressures are found to achieve similarvalues in our study compared to previous studies in CF
patients,33e35 given that our study included a fair number
of younger children who exhibit lower maximal respiratory
pressures.36
Spontaneous breathing in healthy individuals is main-
tained by the balance between Pimean and Pimax. Pimean
describes the respiratory load and consists of the lung and
chest wall elastic loads plus the resistive loads. Pimax de-
scribes the neuromuscular competence and incorporates
properties of respiratory muscle strength, central drive and
neural and neuromuscular transmission.37 The Pimean/Pimax
ratio, which describes the inspiratory muscle energy de-
mands, was significantly lower in the exercise group of our
study. Pimean was not significantly different between the
exercise and control groups of CF patients in our study.
Furthermore, parameters that relate to respiratory drive
such as respiratory rate, inspiratory flow (TV/Ti) and P0.1
were also not found to achieve significant difference be-
tween the exercise and the control groups. It follows that
Table 2 Different types of physical activity undertaken by
the CF patients that form the exercise group of the study. As
some subjects are engaged in more than one activity the
aggregation of the number of subjects participating in
physical activity is bigger than the number of patients
comprising the exercise group of the study.
Physical activity N
Football 15
Basketball 8
Gymnastics 6
Martial arts 3
Cycling 2
Athletics 1
Rowing 1
Running 1
Swimming 1
Tennis 1
Volleyball 1
688 T. Dassios et al.respiratory muscle function assessed by means of PTImus
might be partially preserved in patients with CF who ex-
ercise mainly due to the beneficial effect of exercise on
Pimax. Thus, the ventilatory balance in CF might be rela-
tively maintained in exercising CF patients by strengthening
of the respiratory muscles and not by alleviation of the
respiratory load. Our results are in agreement with Oren-
stein et al.,9 who evaluated respiratory muscle endurance
in CF patients before and after a supervised three month
running program. This study reported that respiratory
muscle endurance, which was assessed by maximal sus-
tained hyperpnea, was significantly increased after the
conditioning period.
Since respiratory muscles are also skeletal muscles, the
more they are exercised the bigger and stronger they are
expected to become. This is not a surprising finding and it
applies to any individual and not only to CF patients. It
would have been interesting to demonstrate a beneficial
effect of exercise on lung function but such a relationshipFigure 1 Pemax in exercising and non-exercising CF patients.
Horizontal lines represent the 5th, 25th, 50th, 75th and 95th
percentile of Pemax values.failed to emerge in our study since exercising and non-
exercising patients did not have significant differences in
lung function indices. A likely explanation for this is that
pressures required for non-forced tidal breathing are
noticeably lower than the ones generated during forced
maneuvers. Nevertheless, increased PTImus values indicate
an increased risk of respiratory muscle fatigue which might
occur if and when the patient is forced to encounter
increased respiratory workload such as during an acute
exacerbation or an acute infection. In these situations
mobilizing respiratory reserves and maintaining adequate
ventilation in the context of a potentially impending res-
piratory fatigue and failure, might be of particular clinical
interest.
The amount of time spent in aerobic activity expressed
as total hours per week was not related to indices of res-
piratory muscle function. This might indicate that a mini-
mum of three forty-five minute workouts per week of
moderate to vigorous intensity is adequate to exert bene-
ficiary effect on respiratory muscle strength, as no further
benefit was exhibited for total training hours per week that
exceeded this number.
With regards to lung function indices, in our study FEV1,
MEF25e75 and FVC were not significantly decreased in CF
patients who did not undertake regular exercise compared
to exercising patients. This is in agreement with previous
studies. Selvadurai et al. found no significant difference in
pulmonary function indices after aerobic training compared
to no physical training.6 Nevertheless, Moorcroft et al.38
and Schneiderman-Walker et al.4 found that long term
aerobic physical training resulted in a slower pulmonary
function decline in the exercise group compared to the
control group.
With regards to anthropometry and nutrition, there were
no statistically significant differences in weight, height,
BMI, BMI z-score and TST between the two groups. Of note,
median body weight in exercising patients was 9 kg higher
compared to the non-exercising ones. Clinically, this might
reflect a possible better nutritional state in exercising pa-
tients or relative differences in body composition. MAMC
and UAMA were significantly increased in the exercise group
as compared to the control group. Furthermore, UAMA was
found to have a significant positive relation to Pimax in the
exercising group. The association of UAMA to respiratory
muscle indices has been reported in previous studies19
while respiratory muscle strength has been shown to be
significantly related to limb muscle strength in patients
with CF.39 This probably demonstrates that reduced muscle
mass in CF patients predisposes to reduced respiratory
muscle strength.
This study has some limitations that need to be consid-
ered. Being a cross-sectional study it does not evaluate the
effect of exercise on individual subjects over a predefined
time-period. It is difficult to assess whether CF patients are
more active because they are fitter or if they are fitter
because they are more active. A longitudinal study might be
better equipped on answering this point. Furthermore, in-
formation relating to physical activity was collected by
questionnaire and the intensity and adherence to the ex-
ercise regimen was not universal or supervised. Thus, the
definition and standardization of exercise is rather limited
and restricts the strength of our conclusions. Unfortunately,
Figure 2 PTImus in exercising and non-exercising CF patients.
Horizontal lines represent the 5th, 25th, 50th, 75th and 95th
percentile of PTImus values.
Exercise and respiratory muscles in cystic fibrosis 689very limited data are available assessing respiratory muscle
function after predefined interventional exercise. Orenstein
et al.9 investigated the effect of a supervised three-month
running program on respiratory muscle endurance in CF
patients and concluded that exercising subjects had sig-
nificantly increased ventilatory muscle endurance, as eval-
uated by sustained hyperpnea scores. Inspiratory muscle
training has resulted in improved respiratory muscle
strength and endurance properties in patients with myas-
thenia gravis,40 although this was a targeted respiratory
muscle training regimen and not a form of aerobic sport
activity. Overall, the population of CF patients incorporated
in the study was in a good respiratory condition, as indicated
by the median spirometric values, limiting thus the possi-
bility of identifying parameters associated with poor respi-
ratory muscle function. Admittedly, FEV1 is a rather
insensitive index in quantifying treatment effects in CF
interventional trials. Novel measures of ventilation in-
homogeneity like multiple breath washout (Lung Clearance
Index) might be better correlated to respiratory muscle
function than spirometry, as it is more frequently abnormal
than spirometry in children with CF.41 Given these meth-
odological limitations, our results still suggest that exercis-
ing CF patients would be more unlikely to succumb to
respiratory fatigue if they were exposed to increased res-
piratory loads, compared to less active CF subjects.
In conclusion, this study demonstrated that maximal
respiratory pressures are significantly higher and PTImus is
significantly lower in exercising CF patients compared to
non-regularly exercising CF patients. Respiratory muscle
strength properties are significantly related to nutritional
indices that describe skeletal muscular status such as UAMA
in exercising CF patients. Regular aerobic exercise might
exert significant benefits on respiratory muscle function in
patients with CF.Conflict of interest statement
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